Eisai Plots A Meticulous Path To CMS Coverage For Lecanemab

US Exec Ivan Cheung Expects ‘More Open Access’ To Drug

Alzheimer's disease; brain and wooden puzzle on pink background
Eisai will piece together a detailed data package for CMS • Source: Shutterstock

More from Neurological

More from Therapeutic Category